《美股業績》德州儀器(TXN.US)季績預測遜預期 市後跌4.6%
美國晶片製造商德州儀器(TXN.US)公布第三季度業績。季度淨利潤按年跌26%至17.09億美元,每股季度攤薄純利1.85美元,勝市場預期。季度收入按年跌14%至45.32億美元,市場預期為45.8億美元。
公司表示,工業市場銷售季內錄得中十位數跌幅,除日本外所有地區表現疲弱。
公司預期現季度收入介乎39.3億至42.7億美元,低於市場預期的44.9億美元。每股盈利介乎1.35至1.57美元,低於市場預期的1.76美元。
德州儀器股價在市後跌4.6%,報140.2美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.